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http://dx.doi.org/10.1016/j.stemcr.2017.02.021SUMMARYIn vitro models of the human blood-brain barrier (BBB) are highly desirable for drug development. This study aims to analyze a set of ten
different BBB culture models based on primary cells, human induced pluripotent stem cells (hiPSCs), and multipotent fetal neural stem
cells (fNSCs).We systematically investigated the impact of astrocytes, pericytes, andNSCs onhiPSC-derived BBB endothelial cell function
and gene expression. The quadruple culture models, based on these four cell types, achieved BBB characteristics including transendothe-
lial electrical resistance (TEER) up to 2,500U cm2 and distinct upregulation of typical BBB genes. A complex in vivo-like tight junction (TJ)
network was detected by freeze-fracture and transmission electron microscopy. Treatment with claudin-specific TJ modulators caused
TEER decrease, confirming the relevant role of claudin subtypes for paracellular tightness. Drug permeability tests with reference sub-
stances were performed and confirmed the suitability of the models for drug transport studies.INTRODUCTION
The blood-brain barrier (BBB) is themost important biolog-
ical barrier between the blood circulation and the central
nervous system (CNS), consisting of specialized blood
endothelial cells (ECs) that line the cerebral capillaries
and are connected by very dense tight junctions (TJs).
Anatomically, the BBB is part of the neurovascular unit,
which maintains the physiological function of the brain
capillary ECs and includes cellular components such as
pericytes, astrocytes, neurons, and microglia (Hawkins
and Davis, 2005). The main functions of the BBB are the
maintenance of CNS homeostasis and the prevention of
penetration of neurotoxic substances as well as pathogens,
such as bacteria and viruses. Besides functioning as a phys-
ical barrier, the BBB plays a major role as a transport and
metabolic barrier (Neuhaus and Noe, 2010).
Models of the BBB serve as very strong tools in drug
development and are important to elucidate further phys-
iological and pathophysiological molecular mechanisms.
Besides in silico and in vivo models, a variety of cellular
in vitro BBBmodels are available, such as transwell models,
dynamic flow-based hollow-fiber models, or microfluidic
devices (Avdeef et al., 2015). So far, primary porcine,
bovine, and rodent ECs are characterized by the best func-894 Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017 j ª 2017 The Auth
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(Vastag and Keseru, 2009). Disadvantages associated with
the use of primary cells are the time- and cost-intensive
isolation processes, the variabilities between cells of
different isolations, and the high consumption of animals
for each new isolation. Access to human primary brain ma-
terial is very limited and restricted to biopsy or autopsyma-
terial from patients with diseases such as epilepsy or brain
tumors. The use of EC lines for BBB modeling helps to
circumvent the disadvantages of primary cells. Immortal-
ized cells of different species, such as murine EC lines
(MBEC4, b.END3, b.END5, cEND, cerebEND) as well as
cell lines from rat (RBE4), cow (t-BBEC-117), pig (PBMEC/
C1-2), and human (hCMEC/D3, hBMEC, TY10, and
BB19) exist (Eigenmann et al., 2013; Avdeef et al., 2015).
These cell lines have the advantage of being usable over
many passages with a higher reproducibility of the results
comparedwith primary cells. Notably, almost all immortal-
ized cell lines form barriers with a transendothelial electri-
cal resistance (TEER) below150U cm2 (Deli et al., 2005). For
drug transport and barrier functionality studies, a minimal
tightness of the BBBmodels with TEER values between 150
and 200 U cm2 has been defined (Gaillard and de Boer,
2000). However, compared with physiological TEER values
of more than 1,500 U cm2, which have been measured inor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
capillaries of rat or frog brains (Crone and Olesen, 1982;
Butt et al., 1990), the discrepancies with current in vitro
models are significant. Another important aspect is the spe-
cies differences that exist between humans and other
mammalian subsets. In particular, the expression and func-
tionality of important BBB transporters such as P-glycopro-
tein are described (Takeuchi et al., 2006; Warren et al.,
2009).
Therefore, there is a significant need for adequate human
BBB models for academic research and the pharmaceutical
industry. Minimal requirements would be the reproduc-
ibility of results, characteristic permeability of reference
components, expression of main BBB transporters, and
physiological cell morphology (Cecchelli et al., 2007).
In recent promising studies, various stem cell types have
been used as an alternative source for BBB remodeling.
Stem cells are self-renewable, can be subsequently differenti-
ated into mature somatic cell types, and serve as a virtually
unlimited independent cell source. In particular, hemato-
poietic stem cells from human umbilical cord blood (Cec-
chelli et al., 2014), circulating endothelial progenitor cells
mobilized from bone marrow (Boyer-Di Ponio et al., 2014),
as well as human induced pluripotent stem cells (hiPSCs)
(Lippmann et al., 2012) have been used for BBB modeling
with promising in vivo-like characteristics, e.g. TEER values
up to 5,000 U cm2 (Lippmann et al., 2014). The addition of
stimulating compounds such as retinoic acid (RA) during
differentiation (Lippmann et al., 2014) and co-culturing
with individual niche cell types, such as pericytes, astro-
cytes, and neural cells, have further improved BBB proper-
ties (Lippmann et al., 2013; Cecchelli et al., 2014).
The aim of this study was to systematically investigate
the individual impact of the different cell types on hiPSC-
derived BBB endothelial cell (hiPS-EC) function as well as
gene expression and therefore establish themost predictive
BBB model. Furthermore, we standardized the methods to
differentiate the corresponding BBB cell types from hiPSCs
as well as human multipotent stem cells. Thus, it will be
technically feasible to generate large quantities of human
cell types from a single cell source and, in combination
with new detection methods, to develop standardized
higher-throughput in vitro assays in drug discovery and
toxicity testing.RESULTS
Characterization of Multipotent and Pluripotent Stem
Cells Used for BBB Modeling
hiPSCs as well as multipotent neural stem cell (NSCs) pro-
vide an effective cell source to generate functional brain
cells and have the advantage of being independent of post-
natal brain tissue biopsy samples. For our studies, we usedthe recently published hiPSC lines IMR90-4 and ARiPS
(Kadari et al., 2014) to differentiate them into BBB ECs
(Lippmann et al., 2012) and hiPS-NSCs. As a physiological
control, NSCs were additionally isolated from fetal brain
tissue (fNSCs). The growth characteristics of hiPSCs are
similar to embryonic stem cells, forming compact colonies
with defined borders, which typically appear in phase-
contrast microscopy (Figure 1D). Colonies were character-
ized by immunofluorescence staining for pluripotency-
associated markers, including OCT3/4 (Figure 1A), SOX2
(Figure 1B), and TRA1-81 (Figure 1C); flow cytometry ana-
lyses demonstrated at least 90% positive staining (data not
shown). For differentiation of hiPSCs into NSCs, a recently
published protocol was used employing neurogenic media
in adherent culture (Yan et al., 2013) with slight modifica-
tions described by Gu¨nther et al. (2016). Morphology of
hiPS-NSCs (Figure 1H) appeared as typical rosette-like struc-
tures, whereas fNSCs (Figure 1L) were more heterogeneous,
some of them with elongated processes. After culturing
bothNSC types in NSCmedium containing basic fibroblast
growth factor (bFGF) and epidermal growth factor (EGF),
NSCs could be further expanded in vitro. NSC identity
was confirmed by staining for early NSC markers such as
SOX1 (Figures 1E and 1I), SOX2 (Figures 1F and 1J), and
NESTIN (Figures 1G and 1K). In contrast, the expression
of pluripotency and astroglial markers could not be de-
tected (data not shown).
Characterization of Differentiated BBB Cell Types
For differentiation of hiPSCs and NSCs to BBB ECs and
astrocytes, the in vivo neurodevelopmental process has to
be mimicked in vitro. For BBB capillary ECs, a co-differen-
tiation of neural and ECs was initiated by treatment with
a so-called unconditioned medium (Lippmann et al.,
2014). The purification of hiPS-ECs was performed using
an EC medium with RA and sub-cultivation on a collagen
IV-/fibronectin-coated matrix. After differentiation for
10 days, hiPS-ECs showed a typical elongated spindle-
shaped morphology, and the cell size was increased
compared with the original hiPSCs (Figure 2A). The hiPS-
ECs were characterized by immunofluorescence staining
for the typical EC marker von Willebrand factor (vWF, Fig-
ure 2B). The TJ-associated protein ZO1 as well as the BBB-
relevant glucose transporter 1 (GLUT1) were homoge-
neously expressed at the cell-cell borders (Figures 2C and
2D). The expression of the adherence junction protein
vascular endothelial cadherin (CDH5) was also detectable,
the endothelial proteins angiopoietin receptor 2 (TIE2) and
PECAM1 (CD31) appeared weaker and less distinct (Figures
S1A–S1C). The functionality of the hiPS-ECs was tested by
an uptake assay with fluorescein isothiocyanate (FITC)-
labeled acetylated low-density lipoprotein. Substance was
taken up by 92.4% of the BBB hiPS-ECs (Figure S1D), andStem Cell Reports j Vol. 8 j 894–906 j April 11, 2017 895
Figure 1. In Vitro Characterization of Pluripotent and Multipotent Stem Cells
(A–C, E–G, and I–K) Immunofluorescence staining of characteristic pluripotent stem cell (A–C) and NSC (E–G and I–K) markers. hiPSCs
express OCT3/4 (A), SOX2 (B), and TRA1-81 (C), NSCs express SOX1 (E and I), SOX2 (F and J), and NESTIN (G and K). Cell nuclei were stained
with DAPI in blue.
(D, H, and L) Phase-contrast image of hiPSCs (D), NSCs differentiated from hiPSCs (H; hiPS-NSC) and NSCs isolated from fetal brain tissue
(L; fNSC).
Scale bars, 100 mm.the fluorescence intensity was lower compared with the
control cell line, human umbilical vein endothelial cells
(Figures S1D–S1F).
Astrocytes differentiated from hiPSCs (hiPS-As, Figures
2E–2H) as well as human primary fetal brain astrocytes
from the cerebral cortex (astrocytes, Figures 2I–2L) were
characterized by immunofluorescence staining for inter-
mediate filament protein glial fibrillary acidic protein
(GFAP, Figures 2F and 2J) as well as for glial-specific
calcium-binding protein B (S100b, Figures 2G and 2K).
The differentiation efficiency of hiPSCs, analyzed by flow
cytometry, was relatively high with 53.8% GFAP-positive
astrocytes (H), although human primary fetal brain astro-
cytes were nearly 100% positive for GFAP (L).
As for astrocytes, human primary pericytes were hetero-
genic in their morphology and marker expression. Cells
showed elongated fibroblast- or MSC-like morphology
and were positively stained for alpha smooth muscle actin
(aSMA, Figure 2N) and platelet-derived growth factor re-
ceptor-beta (PDGFRb, Figure 2O). Flow cytometry demon-
strated 85.2% PDGFRb-positive cells (Figure 2P).
BBB Modeling and Tightness Characterization
To investigate the influence of different cell types on BBB
hiPS-EC integrity, diverse sets of BBB co-cultures were es-896 Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017tablished. As shown in Figure 3A, the differentiated hiPS-
ECs were cultured on a collagen IV-/fibronectin-coated
transwell membrane. The different types of co-culture cells
were seeded in coated wells in the bottom compartment
without direct contact with the hiPS-ECs. We studied the
influence of primary fetal brain astrocytes, hiPS-As, pri-
mary fetal brain pericytes, and NSCs derived from hiPSCs
(hiPS-NSCs) or isolated from fetal brain (fNSCs) on BBB
hiPS-EC integrity. Moreover, we established several combi-
nations of the above-mentioned cell types to study syner-
gistic effects.
After 2 days of co-culture, the TEER was measured as the
first important readout characterizing the paracellular tight-
ness of hiPS-ECs. The cell density of co-culture cellswas kept
constant independent from the co-culture system. A signif-
icant increase in TEER compared with the hiPS-EC mono-
cultures (TEER = 1,198 ± 265) could be obtained by triple
culture of hiPS-ECs, hiPS-NSCs, and pericytes (1,723 ±
90 U cm2) as well as by quadruple culture of hiPS-ECs,
hiPS-NSCs, astrocytes, and pericytes (1,757 ± 320 U cm2)
(Figure 3B). Maximal absolute TEER values ranged between
2,000 U cm2 (mono-culture) and 2,500 U cm2 (triple and
quadruple culture), approximately (Figure 3C).
In addition to TEER measurements, we analyzed BBB
models according to a characteristic gene expression profile
Figure 2. In Vitro Characterization of Differentiated BBB-Relevant Cell Types
(A, E, I, and M) Phase-contrast image of BBB ECs differentiated from hiPSCs: hiPS-ECs (A), astrocytes differentiated from hiPSCs (hiPS-As)
(E), human primary brain astrocytes (I), and pericytes (M).
(B–D) Immunofluorescence staining of characteristic EC markers vWF (B), TJ-associated protein ZO1 (C), and glucose transporter GLUT1
(D). For further characterization, see also Figure S1.
(F–H, J–L, and N–P) The astrocytic proteins GFAP (F and J) and S100b (G and K) were expressed by hiPS-A as well as by human primary brain
astrocytes. Human primary brain pericytes were characterized by staining for aSMA (N) and PDGFRb (O). Cell nuclei were stained with DAPI
in blue. Fluorescence-activated cell sorting analysis of astrocytic protein GFAP (H and L) and pericyte marker PDGFRb (P) reveals
quantification of 53.8% GFAP-positive hiPS-As (H), 99.9% GFAP-positive primary astrocytes (L), and 85.2% primary pericytes.
Scale bars, 100 mm.via qRT-PCR. Genes included the efflux transporter ABCB1,
the glutamate transporter SLC1A1, the glucose transporter
SLC2A1, and TJ componentOCLN. The hiPS-ECmono-cul-
ture (100%) was compared with the different co-culture
settings (Figure 3D), and a 1.5-fold regulation in gene
expression was set as an arbitrary biological threshold. In
concordance with the TEER experiments, the most robust
upregulation was observed for the quadruple culture, indi-
cating effective modeling of the BBB phenotype. Under
these conditions, the expression of ABCB1 was on average
upregulated by 1.5-fold, SLC1A1 by 1.3-fold, SLC2A1 by
1.7-fold, and OCLN by 1.6-fold compared with hiPS-ECsfrom mono-cultures, however statistical significance was
reached only for SLC2A1. The triple culture of hiPS-ECs,
hiPS-NSCs, and pericytes revealed onlymoderate upregula-
tion of 1.3-fold for ABCB1, 1.5-fold for SLC1A1, 1.2-fold for
SLC2A1, and 1.4-fold for OCLN. Other co-culture systems
also yielded moderate upregulation in expression of these
genes, however, with higher variances as in the quadruple
culture. Noteworthy, no significant effects were observed
on gene expression and TEER of hiPS-ECs using the control
colon carcinoma cell line Caco-2 (data not shown).
As the quadruple culture showed the strongest enhance-
ment of the phenotypical development of BBB properties,Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017 897
Figure 3. Establishment of BBB Transwell Models, Tightness Characterization, Gene Expression, and Transporter Functionality
(A) Schematic overview of BBB model establishment in transwell systems. At day 1, in total 53 104 co-culture cells were seeded in the
basolateral compartment. At day 0, 13 106 hiPS-ECs/cm2 were seeded on collagen IV-/fibronectin-coated transwell membranes (no direct
(legend continued on next page)
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Table 1. Overview of the Results of the Permeability Studies
with Paracellular Marker Molecules




Lucifer yellow 1.41 ± 0.25 1.52 ± 0.29 1
Fluorescein 1.39 ± 0.59 1.53 ± 0.67 1
FITC-labeled
dextran 4 kDa
0.0166 ± 0.0037 0.0166 ± 0.0037 3
FITC-labeled
dextran
40 kDa 0.0054 ± 0.0007 0.0054 ± 0.0007 4
Quadruple Culture
Lucifer yellow 1.44 ± 0.34 1.58 ± 0.40 1
Fluorescein 1.26 ± 0.27 1.33 ± 0.29 2
FITC-labeled
dextran 4 kDa




0.0030 ± 0.0004* 0.0030 ± 0.0004* 4
Data are presented as means ± SEM, n = 6–8 from three to four independent
experiments. Statistically significant difference, *p < 0.05, in comparison
with the mono-culture setup. PC, permeability coefficient.
Permeability coefficients and transport rankings are compared between
mono- and quadruple culture models.further analyses focused on the comparison between the
mono-culture and the quadruple setup. To characterize
the functionality of the efflux transporter P-glycoprotein,
we performed transport studies with the substrate rhoda-
mine 123 with and without inhibiting the transporter bycontact with co-culture cells). At day 1, the growth factor concentrati
The models were analyzed at day 2 by TEER measurement, qRT-PCR, w
(B) Ten different variants of BBB models were established as transwe
BBB integrity. TEER was measured at day 2 of co-culture and compar
increased by triple culture of hiPS-ECs with hiPS-NSCs and pericytes as
TEER values are presented as means ± SD after data block-wise correcti
(**p < 0.01).
(C) Overview of the minimal as well as the maximal measured TEER val
across the four independent biological experiments. Absolute TEER
block-wise correction.
(D) qRT-PCR analyses of efflux transporter ABCB1, glutamate transpor
ECs of different co-culture BBBmodels shown as the change in gene exp
shown as means ± SD (n = 3–10); each biological replicate represen
genes for normalization were EEF1A1 and RPL6. The black horizontal
0.001).
(E) Permeability coefficients of the hiPS-ECs (PCcell) after 15 min of tra
and quadruple cultures with and without 100 mM verapamil treatme
replicate represents a new differentiation and co-culture experimentuse of verapamil (Figure 3E). The permeability coefficients
(PCcell) for rhodamine 123 could be significantly increased
in the mono-culture setup as well as in the quadruple
culture by adding verapamil, indicating the correct
transporter functionality and polarization in the cell
membrane.
To characterize the paracellular permeability of the cell
layers in a molecular size-dependent manner, transport
studies with several paracellular marker molecules such as
lucifer yellow (0.44 kDa), fluorescein (0.33 kDa), and
FITC-labeled dextrans (4 and 40 kDa) were accomplished
(Table 1). As expected, lucifer yellow and fluorescein
permeated very similarly (PCcell 1.5 mm/min). FITC-
labeled dextran (4 kDa) migrated about 100-fold slower
than these two small paracellular markers, and the PCs
for 40 kDa FITC-labeled dextran were even smaller (PCcell
0.003–0.0054 mm/min). Corresponding to the TEER values,
comparison with the mono-culture revealed a lower, statis-
tically significant different permeability of 40 kDa FITC-
labeled dextran across the quadruple cultures.
Paracellular permeability is functionally linked to the
expression of junctional molecules, especially of claudins
(CLDN). Therefore, the expression of major TJ and TJ-
associated molecules was analyzed. In addition to occlu-
din (OCLN, Figure 3D), we determined mRNA expression
of CLDN3, CLDN4, CDH5, and TJP1 (ZO-1) of quadruple
cultures in direct comparison with mono-cultures, how-
ever upregulation was mostly below the threshold of
1.5-fold, and no statistical significant effects were de-
tected (data not shown). The expression of all analyzed
genes could be qualitatively confirmed representatively
in mono-cultures by gel electrophoresis of PCR products
(Figure S2). At the protein level, the presence of the TJ pro-
teins CLDN1, CLDN4, and CLDN5 was also confirmed,
again without any statistically significant change inon in the growth medium was reduced to stop hiPS-EC proliferation.
estern blot, electron microscopy, and transport studies.
ll systems to investigate the impact of different co-culture cells on
ed with hiPS-EC mono-culture models. TEER was most significantly
well as by quadruple cultivation, indicated by the red box. Absolute
on (n = 4); each biological replicate represents a new differentiation
ues of all ten variants of BBB models, representing the variabilities
values are represented as measured raw data without manual data
ter SLC1A1, glucose transporter SLC2A1, and occludin OCLN in hiPS-
ression compared with the hiPS-EC mono-culture model. Results are
ts a new differentiation and co-culture experiment. Housekeeping
line indicates an arbitrary threshold of 1.5-fold increase (***p <
nsport of 100 mM rhodamine 123 compared between mono-cultures
nt. Results are shown as means ± SEM (n = 4–6); each biological
(*p < 0.05).
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Figure 4. Expression of Major Tight Junction Proteins and
Relevance of Claudins for Barrier Tightness
(A) Western blot analysis of the TJ proteins (upper line) CLDN1
(22 kDa), CLDN4 (22 kDa), and CLDN5 (23 kDa) compared with
mono-cultures (left lanes) and quadruple cultures (right lanes).
a-Tubulin 52 kDa (lower line) was used in all blots as loading
control. See also Figure S2 for further details.
(B) Quantitative analysis of western blot results of the TJ proteins
CLDN1, CLDN4, and CLDN5 shown as the change in protein
expression compared with the hiPS-EC mono-culture models and
hiPS-ECs of the quadruple cultures.
(C) Effects of cCPEY306W/S313H, cCPEwt, cCPEY306A/L315A proteins on
TEER progression (%) of hiPSC-derived BBB monolayers normalized
to the progression of controls. cCPEwt binds with high affinity to
CLDN3/4 and interacts with CLDN1, whereas cCPEY306W/S313H in-
teracts strongly with CLDN5. The cCPEY306A/L315A control does not
bind to claudins. Data are presented as means ± SD (n = 3–6); in-
dependent biological replicates (*p < 0.05, ***p < 0.001).expression as shown by western blot analysis (Figures 4A
and 4B).
In order to confirm the role of claudins for paracellular
tightness fromBBBhiPS-EC layers, the effects of claudin-spe-
cific TJ modulators on TEER were investigated (Figure 4C).
These TJ modulators were based on the claudin-binding
domain of the Clostridium perfringens enterotoxin (Protze
et al., 2015). Data revealed a significant time- and concentra-900 Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017tion-dependent decrease of TEER after addition of cCPEwt,
which binds with high affinity to CLDN3/4 and interacts
with CLDN1. Furthermore, incubation with CLDN5-bind-
ing cCPEY306W/S313H decreased TEER. On the contrary, appli-
cation of the non-binding control cCPEY306A/L315A showed
no effects on TEER progression. Interestingly, 1 mg/mL
cCPEwt reduced TEER to 32% ± 3% after 4 hr, whereas
1 mg/mL cCPEY306W/S313H (76% ± 10%) did not significantly
disrupt the barrier. Since cCPE_Y306W/S313H has a higher
affinity for CLDN5 than cCPE_wt (Kd 30 nM versus
Kd[ 1 mM; Protze et al., 2015), the results indicated that,
in our model, other claudins next to claudin-5 contribute
strongly to the high TEER values and formation of the para-
cellular barrier.
Freeze-Fracture andTransmission ElectronMicroscopy
To characterize the TJs on the ultrastructural level, cells
were fixed, and freeze-fracture electron microscopy (EM)
was performed. Intramembranous TJ particles were found
on the protoplasmic face (P face, PF) and exoplasmic face
(E face, EF) of the plasma membrane (Figure 5). On the E
face, TJ strands were detected as particles and particle-free
grooves. On the P face, TJ strands were detected partly as
continuous strands andpartly as beadedparticles (Figure 5).
Quadruple cultures and mono-cultures showed variable
although similar complex networks of meshes formed by
branched strands with mixed P/E face association. A ten-
dency to higher complexity was found for the quadruple
cultures (mean number of meshes in the strand network,
33.0 ± 5.0 versus 26.1 ± 2.8; rectangular area with strands,
1.1 ± 0.1 mm2 versus 0.9 ± 0.1 mm2; mesh density, 33.4 ±
2.7 mm2 versus 30.6 ± 2.8 mm2; n > 20). However, no sig-
nificant differences were obtained for any of thesemorpho-
metric parameters. In sum, on the ultrastructural level, for
BBB hiPS-ECs, TJs similar to those of brain capillary ECs of
the BBB were found (Wolburg et al., 1994).
Transmission EM also revealed the presence of complex
TJs, constricting the paracellular gap and connecting two
neighboring hiPS-ECs (Figures 5E–5G). However, no signif-
icant differences of TJs between mono- and quadruple cul-
ture models were found.
Drug Transport Studies
In addition to the restriction of paracellular permeability,
the BBB is also a barrier for transcellular transport. To
describe these properties and to perform a first assessment
about the qualification for drug transport studies, perme-
ation of several reference drugs was studied across the
mono-culture and quadruple culture setup. Calculated
PCs across the total barrier comprising the cell layer and
the membrane support (PCall) revealed mean permeabil-
ities from 3.44 to 26.94 mm/min (Table 2). Especially in
the case of transport studies of compounds migrating via
Figure 5. Ultrastructural Analysis of BBB
Mono-culture and Quadruple Culture
Models
(A–D) Freeze-fracture EM analysis of the TJ
ultrastructure of hiPS-ECs cultured without
(A and B) or with (C and D) co-culture cells.
Similar to brain microcapillary ECs in vivo,
intramembranous TJ particles were found on
the protoplasmic face (P face, PF) and
exoplasmic face (E face, EF) of the plasma
membrane. On the E face, TJ strands were
detected as particles (black arrows) and
particle-free grooves (white arrows). On the
P face, TJ strands were detected as contin-
uous strands (black arrowheads) and as
beaded particles (white arrowheads). Mono-
cultures (A and B) and quadruple cultures
(C and D) showed variable although similar
complex networks of meshes formed by
branched strands with mixed P/E face as-
sociation. Scale bars, 200 nm.
(E–G) Transmission EM micrographs of the
BBB models. Neighboring hiPS-ECs of both
mono-cultures (E and F) and quadruple
cultures (G) are connected by complex TJs
constricting the paracellular space (black arrows). Furthermore, large desmosomes (macula adherens, black hash in E) anchored with
intermediate filaments were detected as well as adhesion points (punctum adherens, black asterisk in G) anchored within the actin
filament network. Scale bars, 200 nm.the transcellular route, correction of the PC for the barrier
formed by the membrane support itself is essential to
obtain the permeability only across the cell layer (PCcell).
This correction procedure revealed significantly increased
PCs. In addition to accounting for cell layer variabilities,
diazepam was used as an internal standard for each com-
pound, and the permeability rankings were calculated
with the PCcell data normalized to the PCcell data of diaz-
epam. These rankings showed that diazepam permeated
fastest followed by caffeine, ibuprofen, celecoxib, diclofe-
nac, loratadine, and rhodamine 123 across the mono-cul-
turemodel. This rankingwas according to the classification
based on literature data for diazepam and caffeine as fast,
ibuprofen, celecoxib, and diclofenac as medium, and lora-
tadine and rhodamine 123 as slow permeating compounds
(Nakazono et al., 1992; Neuhaus et al., 2012; Novakova
et al., 2014). In the case of the quadruple culture, the
mean ratio to diazepam was significantly decreased for
caffeine, from 0.499 to 0.251, leading to a switch in the
ranking position from second to fourth place in compari-
son with the mono-culture setup.
DISCUSSION
In order to closely mimic the BBB in vivo and to optimize
model characteristics, we analyzed a set of different BBBco-culture models based on primary cells (astrocytes, peri-
cytes, and NSCs) and hiPSC-derived cells (hiPS-ECs, hiPS-
NSCs, and hiPS-As). Compared with all existing BBB
models, in vivo-like TEER values of up to 3,600U cm2 could
only been achieved by use of hiPS-ECs (Lippmann et al.,
2012, 2014). To a similar extent, this could also be
confirmed with our current study using the same hiPSC
line IMR90-4 and different co-culture settings. In compari-
son, for the hCMEC/D3 human reference BBB cell line,
TEER levels lower than 40 U cm2 were reported (Weksler
et al., 2005), which could be strongly increased by dynamic
flow culture conditions at best (Cucullo et al., 2008), but
this still does not represent in vivo conditions.
In previous hiPSC studies, hiPS-ECs with specific BBB
characteristics, such as the expression of BBB-relevant TJ
proteins and transporter molecules, were generated by a
co-culture of hiPS-ECs with amixture of neural cells and as-
trocytes (Lippmann et al., 2014). Similarly, we also
included NSCs isolated from fetal human brain tissue or
differentiated from hiPSCs. Besides neural cells, astrocytes
and pericytes are also important BBB niche cells, which
seem to have beneficial effects on barrier integrity and
transporter expression in vitro (Lim et al., 2007; Al Ahmad
et al., 2011; Lippmann et al., 2012). In our studies, we used
primary brain-derived astrocytes and pericytes of human
origin as reference cells in order to stay species consistent.Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017 901




RankingPCall (mm/min) PCcell (mm/min) PCall (mm/min) PCcell (mm/min)
Mono-culture
Diazepam 21.58 ± 0.56a 250.06 ± 31.31a 1 ± 0.0 1
Caffeine 15.15 ± 1.73 51.06 ± 9.90 20.52 ± 1.42 103.36 ± 19.83 0.499 ± 0.043 2
Ibuprofen 17.19 ± 0.89 90.33 ± 14.51 22.25 ± 0.76 377.44 ± 91.69 0.281 ± 0.043 3
Celecoxib 16.21 ± 0.26 42.15 ± 1.82 19.73 ± 0.61 201.81 ± 36.34 0.259 ± 0.060 4
Diclofenac 13.17 ± 0.34 39.98 ± 4.33 22.21 ± 0.45 199.49 ± 39.14 0.224 ± 0.026 5
Loratadine 3.44 ± 0.46 5.78 ± 0.83 18.12 ± 0.83 259.56 ± 118.36 0.036 ± 0.010 6
Rhodamine 123 7.11 ± 2.38 7.44 ± 2.57 26.94 ± 1.09 354.38 ± 84.66 0.024 ± 0.009 7
Quadruple Culture
Diazepam 21.56 ± 0.57a 229.57 ± 24.74a 1 ± 0.0 1
Caffeine 13.32 ± 1.31 34.44 ± 4.40 22.16 ± 1.90 146.74 ± 27.03 0.251 ± 0.046* 4
Ibuprofen 17.20 ± 0.73 86.30 ± 10.18 22.28 ± 0.50 303.67 ± 42.84 0.295 ± 0.032 2
Celecoxib 15.51 ± 0.72 38.98 ± 4.33 18.96 ± 0.93 190.59 ± 60.12 0.296 ± 0.064 2
Diclofenac 13.22 ± 0.39 41.23 ± 5.67 22.17 ± 0.63 227.99 ± 70.30 0.227 ± 0.036 5
Loratadine 3.80 ± 0.52 6.83 ± 0.94 18.28 ± 0.62 202.72 ± 60.81 0.040 ± 0.008 6
Rhodamine 123 4.83 ± 1.47 4.97 ± 1.55 26.17 ± 1.17 288.91 ± 82.16 0.022 ± 0.007 7
Data are presented as means ± SEM, n = 4–6 from three independent experiments. Ratio to diazepam: PCcell value of the substance divided by the PCcell value
of diazepam for each single cell layer; this may lead to differences compared with merely dividing the average PCcell values of the substance by the value for
diazepam. Statistically significant difference, *p < 0.05, in comparison with the ratio in the mono-culture setup. PC, permeability coefficient. Permeability
coefficients: ratios to diazepam and transport rankings are compared between mono-culture and quadruple culture models.
aTransport studies were accomplished with the investigated substance and the internal standard diazepam at the same time; for comparison reasons, the
total average PC values of diazepam of all mono-culture or quadruple culture studies are presented (n = 30).Furthermore, we have applied recent protocols for NSC and
subsequent astrocyte generation from hiPSCs (Reinhardt
et al., 2013; Yan et al., 2013). The advantage of all these pro-
tocols lay in the inexhaustible, rapid, and reliable differen-
tiation of pluripotent stem cells as adherent 2D cultures,
avoiding embryoid body formation and the tendency of
spontaneous cell dedifferentiation (Conti and Cattaneo,
2010).
Taken together, by use of our established, well-standard-
ized protocols, we were able to differentiate hiPSCs into
hiPS-ECs with BBB characteristics within 12 days, hiPS-
NSCswithin 1week, aswell asmultipotentNSCs into astro-
cytes in only 30 days.We demonstrated the pluripotency of
hiPSCs as well as the multipotency of NSCs by expression
of characteristic markers; this was in line with previous
studies (Yu et al., 2007; Yan et al., 2013; Chen et al.,
2015). All further differentiated cells showed specific sets
of markers at the protein as well as gene expression level.
Our study describes the systematic combination of
various cell types in different complex co-culture setups902 Stem Cell Reports j Vol. 8 j 894–906 j April 11, 2017to investigate the influence on hiPS-ECs regarding TEER,
expression of BBB-relevant genes, and transport of specific
substrates. Indeed, themost robust BBB properties could be
achieved by the quadruple culture of BBB ECs with hiPS-
NSCs, primary astrocytes, and pericytes, which is in line
with previous studies (Lippmann et al., 2013, 2014; Cec-
chelli et al., 2014). In contrast to these reports, the BBB
models in our studywere establishedwith constant seeding
densities of co-culture cells allowing us to compare the
direct biological impact on hiPS-ECs. Moreover, instead
of sequentially applied co-cultures, we analyzed the simul-
taneous co-culture effects to reflect complex cell-cell inter-
actions and the in vivo-like conditions. Thus, the tightness
and expression of BBB-relevant genes in the quadruple cul-
ture was significantly increased. Noteworthy, altered TEER
did not correspond with specific upregulation of TJ-associ-
ated genes, which confirms recent data from the Shusta
group (Canfield et al., 2016).
The paracellular barrier against small ions and molecules
in hiPS-EC cultures formed by TJs were functionally
detected by high TEER and low flux of paracellular marker
molecules. On the ultrastructural level, the presence of TJs
was clearly demonstrated by freeze-fracture EM as well as
transmission EM. The TJs appeared to be similar to those re-
ported earlier for other hiPS-ECs (Lippmann et al., 2012).
Furthermore, we found complex networks of meshes
formed by branched TJ strands, which at least partly corre-
lates with barrier properties (Claude, 1978) and are compa-
rable with those of brain ECs in vivo (Wolburg et al., 1994;
Kniesel et al., 1996). Also similar to the BBB, in vivo intra-
membranous TJ particles were strongly associated with the
P face, a parameter that correlates with tightness of the bar-
rier. In general, tight brain capillary ECs form TJs with a
characteristic mixed P/E face association with more than
50% of the TJ particles on the P face (Wolburg et al.,
1994; Kniesel et al., 1996). It was shown that the ultrastruc-
ture of TJs including the P/E face association is at least
partly dependent on the CLDN composition (Liebner
et al., 2000) and CLDN subtype-specific interactions.
Hence, the mixed P/E face association found for hiPS-EC
cultures fits with the expression of CLDN5 together with
CLDN1, 3, or 4 (Furuse et al., 1999; Piontek et al., 2011).
These ultrastructural findings were also consistent with
TEER experiments and cCPE-based claudin-binding TJ
modulators, showing that several claudins were probably
responsible for high TEER values in our hiPSC-derived
BBB model (Protze et al., 2015). All the claudins found to
be expressed in hiPS-ECswere reported to be potentially ex-
pressed in the BBB (Kratzer et al., 2012). In sum, the data
presented in this study suggest the quadruple culture as
an in vitro BBB model with in vivo-like TJ characteristics.
In addition to the comprehensive characterization of the
paracellular barrier of our models, transport studies with
smallmolecules known for permeating via the transcellular
route were accomplished. According to the literature, diaz-
epam permeated fastest, followed by caffeine, ibuprofen,
celecoxib, diclofenac, loratadine, and rhodamine 123 in
the mono-culture setup. In in vitro tests, caffeine, a more
hydrophilic compound, was shown to permeate almost
as fast as diazepam, a lipophilic compound often used as
a fast-migrating transcellular marker that does not interact
with efflux transporters (Zhao and Pollack, 2009; Mealey
et al., 2010). On the contrary, in vivo data revealed that
caffeine was significantly slower than diazepam, probably
due to interactions with active transporters (Nakazono
et al., 1992; Yusof et al., 2014). These in vivo observations
were also reflected in our models. Moreover, transport
of caffeine was significantly further decreased in the
quadruple culture compared with the mono-culture, indi-
cating an even more in vivo-like phenotype in the
quadruple culture. In concordance with in vitro data
obtained from BBB models based on rat primary cells,
ibuprofen was also faster than diclofenac in our models(Novakova et al., 2014). Loratadine and rhodamine 123
are known to be strong substrates of the efflux pump
P-glycoprotein and to permeate significantly slower than
diazepam (Obradovic et al., 2007; Neuhaus et al., 2012).
This was also found in ourmodels. However, it is important
to point out that the slowest compounds, loratadine and
rhodamine 123, were still significantly faster than the para-
cellular markers fluorescein or lucifer yellow in our models
(PCcell 5–8 mm/min versus 1.5 mm/min). Lippmann et al.
(2012) published a dynamic range of PCs with about
40-fold between diazepam and sucrose; in our models, a
150-fold difference was achieved comparing PCcell values
from diazepam to fluorescein. However, in this case, it is
important to mention that Lippmann et al. (2012) did
not include blank values in their calculation procedure,
used another transport study design (sampling versus
transferring) as well as other transport buffer compositions,
and probably applied different substance concentrations.
Considering these variables, the published PC of diazepam
(11 mm/min) was in a similar range to the PCall values for
diazepam in our studies (18–27 mm/min). With regard to
the paracellular tightness, PCs for low-molecular-weight
markers such as sucrose (0.342 kDa) of high-fidelity BBB an-
imal in vitro models were between 0.1 and 1 mm/min,
which was also in a similar range to our models (Perriere
et al., 2007; Malina et al., 2009). Moreover, the quadruple
model revealed an average PC of 0.0106 mm/min for
FITC-labeled dextran 4 kDa and 0.0030 mm/min for FITC-
labeled dextran 40 kDa. In comparison with these data,
the standard human BBB cell line hCMEC/D3 formed
significantly leakier cell layers (fluorescein, 55 mm/min;
FITC-labeled dextran 4 kDa, 8.3 mm/min) (Forster et al.,
2008). Taken together, compared with the mono-culture,
the quadruple culture provides a model with significantly
higher barrier integrity and altered transcellular drug trans-
port. For substances whose transport is significantly
affected by drug transporters (influx or efflux), a tight
human model could be preferential. In terms of BBB-spe-
cific gene abundance, we saw only moderate effects, sug-
gesting that protein organization and localization might
be much more influenced by the co-culture and causative
for altered BBB function. Consequently, methods to eval-
uate BBB model integrity might indeed include non-inva-
sive TEER measurement, permeation studies with paracel-
lular markers, and estimation of BBB transporter activity.
In future experiments, long-term cultures of BBB models
could be of interest, offered potentially by the use of dy-
namic flow culture conditions, to further study chronic dis-
eases such as Alzheimer’s disease and Parkinson’s disease.
In this respect, there is increasing interest in so-called or-
gan-on-a-chip technologies, which will allow the study of
complex organ interaction, e.g., of the BBB and liver, under
dynamic flow conditions. Furthermore, based on recentStem Cell Reports j Vol. 8 j 894–906 j April 11, 2017 903
differentiation protocols for hiPSC-derived astrocytes and
pericytes, our approach could be further developed to
establish fully isogenic BBB models (Orlova et al., 2014;
Canfield et al., 2016). With these protocols in hand,
isogenic cultures will be possible in future applications.
Finally, by working with patient-specific cells, reprog-
rammed to pluripotent stem cells, BBBmodels from one in-
dividual donor could be established, which might lead to
more effective personalized therapies or novel drugs
(Grskovic et al., 2011; Okano and Yamanaka, 2014).EXPERIMENTAL PROCEDURES
Co-culture Experiments in Transwell Settings
To investigate the influence of different co-culture setups on BBB
EC integrity, the same cell density of 5 3 104 cells per cm2 was
seeded in 24-well plates (Sigma-Aldrich) in all experiments. Plate
coating depended on individual co-culture cell type: astrocytes,
pericytes, and combinations of both were cultured on 10 mg/mL
poly-L-lysine (PELOBiotech); hiPS-NSCs and fNSCs as well as all
respective combinations on 15 mg/mL poly-L-ornithine (Sigma-Al-
drich) + 1 mg/mL laminin (Sigma-Aldrich); and hiPSC-As onMatri-
gel (BD Biosciences; 1:100 in DMEM/F-12, Life Technologies).
Seeding was performed 24 hr prior to co-culture with BBB hiPS-
ECs; seeding density is described in Table S1.
NSCs from fetal brain tissuewere isolated after induced abortions
between the 11th and 12th weeks of pregnancy. Informed consent
was obtained beforehand, and the study was approved by the local
ethics committee of the Julius-Maximilians-University Wu¨rzburg
(reference number 151/14).
After 24 hr of pre-culture, BBB hiPS-ECs were sub-cultured
on collagen IV-coated (Sigma-Aldrich) and fibronectin-coated
(Life Technologies) 24-well inserts (Sigma-Aldrich) andmaintained
for 24 hr as amono- or co-culture in ECmedium+hbFGF + RA (hu-
man Endothelial-SFM [Life Technologies] supplemented with
1% platelet-poor plasma-derived bovine serum [Alfa Aesar],
20 ng/mL hbFGF [PeproTech], and 10 mM all-trans RA [Sigma-Al-
drich]). Thereafter, cultures were continued and combined with a
24-hr treatment with EC medium (without hbFGF and RA).
Detailed information on coating preparation andmedium compo-
sition is given in the Supplemental Information.
Transport Studies
Transport assays were performed in 24-well transwells under
serum-free conditions on a rocking shaker KM-2 AKKU (Edmund
Bu¨hler) at 100 rpm, 37C, 95% humidity, and 5% CO2. All sub-
stances were dissolved at their specific concentrations (see Table
S2) in human Endothelial-SFM. In the case of FITC-labeled dex-
trans, the dissolved stock solutions were purified from residual-
free FITC before use by ultrafiltration using Amicon 3 kDa filter
tubes (Millipore). The test substance (200 mL) was pipetted on the
apical (top) side of the BBB models. The basolateral (bottom) side
was supplied with 800 mL of pure human Endothelial-SFM. Every
15 min, inserts were transferred into new pre-warmed wells filled
with 800 mL of pure human Endothelial-SFM. Incubation times
for FITC-labeled dextran reference compounds were 0.5 hr,904 Stem Cell Reports j Vol. 8 j 894–906 j April 11, 20171.5 hr, 3.5 hr, 7.5 hr, and 30.5 hr. The transport assay was stopped
after 60min (FITC-labeled dextran, 30.5hr). Transporter inhibition
experiments with verapamil were performed for 15 min; to block
the function of P-glycoprotein, rhodamine 123 and verapamil
had to be combined to their final concentrations. Transport in
quadruple culture models and hiPS-EC mono-cultures were
compared. As control, all substances were also incubated on empty
collagen IV-/fibronectin-coated inserts. For comparison reasons,
transport assayswere performedwithout the co-cultures to prevent
drug absorption by these cells. All permeability studies were per-
formed in duplicate and three independent biological replicates.
Supernatants of samples, whichwere precipitated with acetonitrile
(VWR) (1:2) at 4C for 60 min and centrifuged at 12,000 rpm for
10 min, were analyzed by high-performance liquid chromatog-
raphy (HPLC) (detailed method description, see Table S3). Peak
areaswereused to calculate PCs. PCall andPCcell following the clear-
ance principle as previously published (Novakova et al., 2014).
Statistical Analysis
All experimentswereperformedat least three times. The level of sta-
tistical significancewas set at p < 0.05, indicatedwith an asterisk (*).
Detailed information about the individual statistical tests applied
can be found in the Supplemental Information.
SUPPLEMENTAL INFORMATION
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